- Home
- VSTE vs VSTM Comparison
VSTE vs VSTM Comparison
Compare VSTE & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- VSTM
- Stock Information
- Founded
- VSTE 2009
- VSTM 2010
- Country
- VSTE Australia
- VSTM United States
- Employees
- VSTE N/A
- VSTM N/A
- Industry
- VSTE
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- VSTE
- VSTM Health Care
- Exchange
- VSTE Nasdaq
- VSTM Nasdaq
- Market Cap
- VSTE 30.0M
- VSTM 132.0M
- IPO Year
- VSTE N/A
- VSTM 2012
- Fundamental
- Price
- VSTE $2.42
- VSTM $3.88
- Analyst Decision
- VSTE
- VSTM Strong Buy
- Analyst Count
- VSTE 0
- VSTM 8
- Target Price
- VSTE N/A
- VSTM $14.57
- AVG Volume (30 Days)
- VSTE 14.1K
- VSTM 1.1M
- Earning Date
- VSTE 01-01-0001
- VSTM 11-06-2024
- Dividend Yield
- VSTE N/A
- VSTM N/A
- EPS Growth
- VSTE N/A
- VSTM N/A
- EPS
- VSTE N/A
- VSTM N/A
- Revenue
- VSTE $342,000.00
- VSTM $10,000,000.00
- Revenue This Year
- VSTE N/A
- VSTM N/A
- Revenue Next Year
- VSTE N/A
- VSTM $125.69
- P/E Ratio
- VSTE N/A
- VSTM N/A
- Revenue Growth
- VSTE N/A
- VSTM N/A
- 52 Week Low
- VSTE $0.83
- VSTM $2.10
- 52 Week High
- VSTE $12.00
- VSTM $14.22
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- VSTM 63.77
- Support Level
- VSTE $0.83
- VSTM $3.11
- Resistance Level
- VSTE $1.09
- VSTM $3.76
- Average True Range (ATR)
- VSTE 0.10
- VSTM 0.33
- MACD
- VSTE 0.03
- VSTM 0.04
- Stochastic Oscillator
- VSTE 92.08
- VSTM 94.26
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.